Interaction Check

This page cannot be displayed because your browser has been configured to disable JavaScript, also known as "Active Scripting".Please change your settings and refresh the page.

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

MultiCheck Results - 8 Interactions

Avoid/Use Alternative
Aranelle (norethindrone/ ethinyl estradiol) + Kaitlib Fe (norethindrone/ ethinyl estradiol)
Avoid/Use Alternative ethinyl estradiol (contraceptive) + ethinyl estradiol (contraceptive) avoid combo: combo may incr. risk of HTN, thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy) norethindrone (contraceptive) + norethindrone (contraceptive) avoid combo: combo may incr. risk of thromboembolism, other adverse effects (additive effects, duplicate therapy)
Monitor/Modify Tx
Admelog (insulin lispro) + Aranelle (norethindrone/ ethinyl estradiol)
Monitor/Modify Tx insulin + ethinyl estradiol (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) insulin + norethindrone (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)
Admelog (insulin lispro) + Kaitlib Fe (norethindrone/ ethinyl estradiol)
Monitor/Modify Tx insulin + ethinyl estradiol (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) insulin + norethindrone (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)
Aranelle (norethindrone/ ethinyl estradiol) + Inspra (eplerenone)
Monitor/Modify Tx ethinyl estradiol (contraceptive) + eplerenone monitor potassium, BP: combo may incr. eplerenone levels, risk of hyperkalemia, other adverse effects; may decr. antihypertensive agent efficacy (hepatic metabolism inhibited; antagonistic effects)
Inspra (eplerenone) + Kaitlib Fe (norethindrone/ ethinyl estradiol)
Monitor/Modify Tx eplerenone + ethinyl estradiol (contraceptive) monitor potassium, BP: combo may incr. eplerenone levels, risk of hyperkalemia, other adverse effects; may decr. antihypertensive agent efficacy (hepatic metabolism inhibited; antagonistic effects)